Neuroinflammatory Mechanisms in Epilepsy and Treatment

Epilepsy is increasingly understood as a disorder in which recurrent seizures and brain inflammation form a vicious cycle. In response to excessive neuronal activity, resident glial cells—including microglia and astrocytes—become activated and release cytokines and chemokines that alter neuronal excitability and promote further seizure activity. Peripheral immune cells can infiltrate the brain through a compromised blood–brain barrier, amplifying central inflammation. Key inflammatory pathways involve proinflammatory mediators such as interleukin-1β and tumour necrosis factor-α, as well as enzymes like cyclooxygenase-2 that generate prostaglandins. Pattern-recognition receptors on microglia, notably Toll-like receptor 9, detect damage-associated molecular patterns and perpetuate inflammatory signalling. Therapeutic strategies are shifting towards immunomodulation, targeting specific cytokines, glial signalling pathways and metabolic enzymes. Advances in imaging of translocator protein and in vitro modelling of glial phenotypes are refining our understanding of spatiotemporal dynamics of neuroinflammation. Together, these findings underscore the importance of integrated central and peripheral immune responses in epileptogenesis and invite treatments that combine anticonvulsant with anti-inflammatory approaches.

Research from Nature Portfolio

Recent studies have highlighted a homeostatic role for innate immune signalling in limiting aberrant neurogenesis after seizures. In particular, microglial activation of Toll-like receptor 9 in the hippocampus senses self-DNA released from damaged neurons and triggers tumour necrosis factor-α production. This feedback attenuates abnormal proliferation of neural progenitors that would otherwise contribute to cognitive decline and recurrent seizure severity. Mice deficient in this receptor pathway display exacerbated cognitive deficits and more frequent seizures, demonstrating that selective engagement of innate immunity can preserve circuit integrity following status epilepticus.

Neuroinflammatory Mechanisms in Epilepsy and Treatment publication trend

The graph below shows the total number of articles in neuroinflammatory mechanisms in epilepsy and treatment across all publications each year (not limited to Nature Index journals).

Technical terms

Neuroinflammation: Innate immune response within the central nervous system involving glial activation and inflammatory mediators.

Microglia: Resident immune cells of the brain that detect damage and orchestrate inflammatory responses.

Cytokine: Small protein released by immune or glial cells that modulates inflammation and cell signalling.

Chemokine: Subclass of cytokines that directs migration of immune cells to sites of injury or inflammation.

Blood–brain barrier: Endothelial boundary that regulates passage of cells and molecules between the circulation and brain.

Th1/Th2 subsets: Distinct CD4+ T helper cell populations defined by their cytokine profiles and immune functions.

Cyclooxygenase-2 (COX-2): Enzyme induced during inflammation to synthesise proinflammatory prostaglandins.

Toll-like receptor 9 (TLR9): Pattern-recognition receptor in microglia that senses DNA fragments and triggers inflammatory signalling.

References

1. Th1/Th2 Imbalance in Peripheral Blood Echoes Microglia State Dynamics in CNS During TLE Progression. Advanced Science (2024).
2. Role of Inflammatory Mediators in the Pathogenesis of Epilepsy. Mediators of Inflammation (2014).
3. TLR9 signalling in microglia attenuates seizure-induced aberrant neurogenesis in the adult hippocampus. Nature Communications (2015).
4. Cyclooxygenase-2 (COX-2) inhibitors: future therapeutic strategies for epilepsy management. Journal of Neuroinflammation (2019).
5. Systemic autoinflammation with intractable epilepsy managed with interleukin-1 blockade. Journal of Neuroinflammation (2018).
6. Brain inflammation in a chronic epilepsy model: Evolving pattern of the translocator protein during epileptogenesis. Neurobiology of Disease (2015).
7. PET imaging of brain inflammation during early epileptogenesis in a rat model of temporal lobe epilepsy. EJNMMI Research (2012).